Literature DB >> 24930037

Aberrant gut microbiota composition at the onset of type 1 diabetes in young children.

Marcus C de Goffau1, Susana Fuentes, Bartholomeus van den Bogert, Hanna Honkanen, Willem M de Vos, Gjalt W Welling, Heikki Hyöty, Hermie J M Harmsen.   

Abstract

AIMS/HYPOTHESIS: Recent studies indicate that an aberrant gut microbiota is associated with the development of type 1 diabetes, yet little is known about the microbiota in children who have diabetes at an early age. To this end, the microbiota of children aged 1-5 years with new-onset type 1 diabetes was compared with the microbiota of age-matched healthy controls.
METHODS: A deep global analysis of the gut microbiota composition was established by phylogenetic microarray analysis using a Human Intestinal Tract Chip (HITChip).
RESULTS: Principal component analyses highlighted the importance of age when comparing age-matched pairs. In pairs younger than 2.9 years, the combined abundance of the class Bacilli (notably streptococci) and the phylum Bacteroidetes was higher in diabetic children, whereas the combined abundance of members of Clostridium clusters IV and XIVa was higher in the healthy controls. Controls older than 2.9 years were characterised by a higher fraction of butyrate-producing species within Clostridium clusters IV and XIVa than was seen in the corresponding diabetic children or in children from the younger age groups, while the diabetic children older than 2.9 years could be differentiated by having an increased microbial diversity. CONCLUSIONS/
INTERPRETATION: The results from both age groups suggest that non-diabetic children have a more balanced microbiota in which butyrate-producing species appear to hold a pivotal position.

Entities:  

Mesh:

Year:  2014        PMID: 24930037     DOI: 10.1007/s00125-014-3274-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  42 in total

Review 1.  Infections in patients with diabetes mellitus.

Authors:  N Joshi; G M Caputo; M R Weitekamp; A W Karchmer
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

2.  Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends.

Authors:  P Onkamo; S Väänänen; M Karvonen; J Tuomilehto
Journal:  Diabetologia       Date:  1999-12       Impact factor: 10.122

Review 3.  The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis?

Authors:  A Hague; A J Butt; C Paraskeva
Journal:  Proc Nutr Soc       Date:  1996-11       Impact factor: 6.297

4.  Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.

Authors:  Jean-Pierre Furet; Ling-Chun Kong; Julien Tap; Christine Poitou; Arnaud Basdevant; Jean-Luc Bouillot; Denis Mariat; Gérard Corthier; Joël Doré; Corneliu Henegar; Salwa Rizkalla; Karine Clément
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

5.  The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998.

Authors:  A Pundziute-Lyckå; G Dahlquist; L Nyström; H Arnqvist; E Björk; G Blohmé; J Bolinder; J W Eriksson; G Sundkvist; J Ostman
Journal:  Diabetologia       Date:  2002-05-08       Impact factor: 10.122

6.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

Authors:  Luying Peng; Zhong-Rong Li; Robert S Green; Ian R Holzman; Jing Lin
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

7.  Improved extraction of PCR-quality community DNA from digesta and fecal samples.

Authors:  Zhongtang Yu; Mark Morrison
Journal:  Biotechniques       Date:  2004-05       Impact factor: 1.993

8.  The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations.

Authors:  M D Collins; P A Lawson; A Willems; J J Cordoba; J Fernandez-Garayzabal; P Garcia; J Cai; H Hippe; J A Farrow
Journal:  Int J Syst Bacteriol       Date:  1994-10

9.  Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.

Authors:  Christopher T Brown; Austin G Davis-Richardson; Adriana Giongo; Kelsey A Gano; David B Crabb; Nabanita Mukherjee; George Casella; Jennifer C Drew; Jorma Ilonen; Mikael Knip; Heikki Hyöty; Riitta Veijola; Tuula Simell; Olli Simell; Josef Neu; Clive H Wasserfall; Desmond Schatz; Mark A Atkinson; Eric W Triplett
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  119 in total

1.  Dietary intake of soluble fiber and risk of islet autoimmunity by 5 y of age: results from the TEDDY study.

Authors:  Andreas Beyerlein; Xiang Liu; Ulla M Uusitalo; Minna Harsunen; Jill M Norris; Kristina Foterek; Suvi M Virtanen; Marian J Rewers; Jin-Xiong She; Olli Simell; Åke Lernmark; William Hagopian; Beena Akolkar; Anette-G Ziegler; Jeffrey P Krischer; Sandra Hummel
Journal:  Am J Clin Nutr       Date:  2015-07-08       Impact factor: 7.045

2.  Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.

Authors:  Mark A Atkinson; Matthias von Herrath; Alvin C Powers; Michael Clare-Salzler
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

Review 3.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

4.  Sex-dependent effects of bisphenol A on type 1 diabetes development in non-obese diabetic (NOD) mice.

Authors:  Joella Xu; Guannan Huang; Tamas Nagy; Quincy Teng; Tai L Guo
Journal:  Arch Toxicol       Date:  2019-01-02       Impact factor: 5.153

Review 5.  Intestinal Lactobacillus in health and disease, a driver or just along for the ride?

Authors:  Dustin D Heeney; Mélanie G Gareau; Maria L Marco
Journal:  Curr Opin Biotechnol       Date:  2017-09-01       Impact factor: 9.740

Review 6.  Microbiota and metabolic diseases.

Authors:  Alessia Pascale; Nicoletta Marchesi; Cristina Marelli; Adriana Coppola; Livio Luzi; Stefano Govoni; Andrea Giustina; Carmine Gazzaruso
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

7.  Non-lethal growth inhibition by arresting the starch utilization system of clinically relevant human isolates of Bacteroides dorei.

Authors:  Anthony D Santilli; Jordan T Russell; Eric W Triplett; Kristi J Whitehead; Daniel C Whitehead
Journal:  Medchemcomm       Date:  2019-07-05       Impact factor: 3.597

Review 8.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

Review 9.  The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

10.  Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children.

Authors:  Alexandra Paun; Christopher Yau; Shahab Meshkibaf; Michelle C Daigneault; Leili Marandi; Steven Mortin-Toth; Amit Bar-Or; Emma Allen-Vercoe; Philippe Poussier; Jayne S Danska
Journal:  Sci Immunol       Date:  2019-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.